Cytoarchitectural and kinetic features in the histological evaluation of follicular thyroid neoplasms

Histopathology

Volumn 50, Issue 6, 2007, Pages 750-763

  Arif, S ^a   Patel, J ^a   Blanes, A ^b   Diaz Cano, S J ^b,c,d  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF MÁLAGA   (Spain)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Anaplastic carcinoma; Follicular adenoma; Follicular carcinoma; Growth patterns; Inflammation; Nuclear features; Thyroid

Indexed keywords

KI 67 ANTIGEN;

APOPTOSIS; ARTICLE; CANCER INVASION; CELL NUCLEUS; CHEMICAL LABELING; CHROMATIN; CLINICAL FEATURE; CONTROLLED STUDY; CYTOARCHITECTURE; CYTOPLASM; DISEASE MARKER; ENCAPSULATION; FISHER EXACT TEST; FOLLICULAR CARCINOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; KINETICS; LYMPHOCYTE; MAJOR CLINICAL STUDY; NUCLEOLUS; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; STUDENT T TEST; THYROID ADENOMA; THYROID CARCINOMA; THYROID NODULE; THYROID TUMOR; UPREGULATION;

ADENOMA; APOPTOSIS; CARCINOMA, PAPILLARY, FOLLICULAR; CELL NUCLEUS; CELL PROLIFERATION; DIAGNOSIS, DIFFERENTIAL; HUMANS; SENSITIVITY AND SPECIFICITY; THYROID NEOPLASMS; THYROID NODULE;

EID: 34247601129     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2007.02680.x     Document Type: Article

References (37)

1. Derwahl M, Studer H. Hyperplasia versus adenoma in endocrine tissues: are they different? Trends Endocrinol. Metab. 2002 13 23 28.
2. Hirokawa M, Carney JA, Goellner JR et al. Observer variation of encapsulated follicular lesions of the thyroid gland. Am. J. Surg. Pathol. 2002 26 1508 1514.
3. Lloyd R, DeLellis R, Heitz P, Eng C. Pathology and genetics of tumours of endocrine organs. Geneva: WHO Press 2004.
4. Tallini G, Garcia-Rostan G, Herrero A et al. Downregulation of p27KIP1 and Ki67/Mib1 labeling index supports the classification of thyroid carcinoma into prognostically relevant categories. Am. J. Surg. Pathol. 1999 23 678 685.
5. Diaz-Cano SJ, Blanes A, Rubio J, Matilla A, Wolfe HJ. Molecular evolution and intratumor heterogeneity by topographic compartments in muscle-invasive transitional cell carcinoma of the urinary bladder. Lab. Invest. 2000 80 279 289.
6. Blanes A, Rubio J, Martinez A, Wolfe HJ, Diaz-Cano SJ. Kinetic profiles by topographic compartments in muscle-invasive transitional cell carcinomas of the bladder: role of TP53 and NF1 genes. Am. J. Clin. Pathol. 2002 118 93 100.
7. Blanes A, Sanchez-Carrillo JJ, Diaz-Cano SJ. Topographic molecular profile of pheochromocytomas: role of somatic down-regulation of mismatch repair. J. Clin. Endocrinol. Metab. 2006 91 1150 1158.
8. Rosai J, Carcangiu ML, DeLellis RA. Tumors of the thyroid gland. In Rosai J, Sobin L eds. Atlas of tumor pathology, 3rd series. Washington, DC: Armed Forces Institute of Pathology 1991.
9. Lloyd RV, Douglas BR, Young WRJ. Endocrine diseases. Washington, DC: American Registry of Pathology and the Armed Forces Institute of Pathology 2002.
10. de Miguel M, Blanes A, Galera H, Diaz-Cano SJ. Critical reappraisal of pathologic criteria for the diagnosis of adrenocortical proliferative lesions. J. Pathol. 2002 198 (Suppl. 50A (Abstract).
11. Pozo L, Camacho F, Rios-Martin JJ, Diaz-Cano SJ. Cell proliferation in skin tumors with ductal differentiation: patterns and diagnostic applications. J. Cutan. Pathol. 2000 27 292 297.
12. Pozo L, Naase M, Cerio R, Blanes A, Diaz-Cano SJ. Critical analysis of histologic criteria for grading atypical (dysplastic) melanocytic nevi. Am. J. Clin. Pathol. 2001 115 194 204.
13. Diaz-Cano SJ, de Miguel M, Blanes A, Tashjian R, Galera H, Wolfe HJ. Clonality as expression of distinctive cell kinetics patterns in nodular hyperplasias and adenomas of the adrenal cortex. Am. J. Pathol. 2000 156 311 319.
14. Diaz-Cano SJ, de Miguel M, Blanes A, Tashjian R, Galera H, Wolfe HJ. Clonal patterns in phaeochromocytomas and MEN-2A adrenal medullary hyperplasias: histological and kinetic correlates. J. Pathol. 2000 192 221 228.
15. LiVolsi VA, Baloch ZW. Follicular neoplasms of the thyroid: view, biases, and experiences. Adv. Anat. Pathol. 2004 11 279 287.
16. van Heerden JA, Hay ID, Goellner JR et al. Follicular thyroid carcinoma with capsular invasion alone: a nonthreatening malignancy. Surgery 1992 112 1130 1136 discussion 1136 1138.
17. Lloyd RV, Erickson LA, Casey MB et al. Observer variation in the diagnosis of follicular variant of papillary thyroid carcinoma. Am. J. Surg. Pathol. 2004 28 1336 1340.
18. Galera-Davidson H, Bibbo M, Bartels PH et al. Differential diagnosis between follicular adenoma and follicular carcinoma of the thyroid by marker features. Anal. Quant. Cytol. Histol. 1986 8 195 200.
19. Galera-Davidson H, Bibbo M, Bartels PH, Dytch HE, Puls JH, Wied GL. Correlation between automated DNA ploidy measurements of Hürthle-cell tumors and their histopathologic and clinical features. Anal. Quant. Cytol. Histol. 1986 8 158 167.
20. Montironi R, Alberti R, Sisti S, Braccischi A, Scarpelli M, Mariuzzi GM. Discrimination between follicular adenoma and follicular carcinoma of the thyroid: preoperative validity of cytometry on aspiration smears. Appl. Pathol. 1989 7 367 374.
21. Montironi R, Braccischi A, Scarpelli M, Sisti S, Alberti R. Well differentiated follicular neoplasms of the thyroid: reproducibility and validity of a 'decision tree' classification based on nucleolar and karyometric features. Cytopathology 1992 3 209 222.
22. Hough AJ, Hollifield JW, Page DL, Hartmann WH. Prognostic factors in adrenal cortical tumors. A mathematical analysis of clinical and morphologic data. Am. J. Clin. Pathol. 1979 72 390 399.
23. van Slooten H, Schaberg A, Smeenk D, Moolenaar AJ. Morphologic characteristics of benign and malignant adrenocortical tumors. Cancer 1985 55 766 773.
24. Weiss LM. Comparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors. Am. J. Surg. Pathol. 1984 8 163 169.
25. Schantz A, Castleman B. Parathyroid carcinoma. A study of 70 cases. Cancer 1973 31 600 605.
26. Alvord EC Jr. Is necrosis helpful in the grading of gliomas? Editorial opinion. J. Neuropathol. Exp. Neurol. 1992 51 127 132.
27. Barker FG 2nd., Davis RL, Chang SM, Prados MD. Necrosis as a prognostic factor in glioblastoma multiforme. Cancer 1996 77 1161 1166.
28. Gleason DF. Histologic grade, clinical stage, and patient age in prostate cancer. NCI Monogr. 1988 15 18.
29. Diaz-Cano SJ. MAP kinase common pathway in thyroid carcinomas of follicular differentiation. J. Pathol. 2006 210 133 134.
30. Diaz-Cano SJ. Adrenal medullary proliferation and clonality. In 87th Annual Meeting of the US and Canadian Academy of Pathology; 28 February to 6 March 1998; Boston, MA, USA. 1998.
31. Diaz-Cano SJ, Blanes A, Wolfe HJ. PCR techniques for clonality assays. Diagn. Mol. Pathol. 2001 10 24 33.
32. Diaz-Cano SJ. Designing a molecular analysis of clonality in tumours. J. Pathol. 2000 191 343 344.
33. Diaz-Cano SJ. Clonality studies in the analysis of adrenal medullary proliferations: application principles and limitations. Endocr. Pathol. 1998 9 301 316.
34. Pomerance M, Quillard J, Chantoux F, Young J, Blondeau JP. High-level expression, activation, and subcellular localization of p38-MAP kinase in thyroid neoplasms. J. Pathol. 2006 209 298 306.
35. Lahat N, Sheinfeld M, Sobel E, Kinarty A, Kraiem Z. Divergent effects of cytokines on human leukocyte antigen-DR antigen expression of neoplastic and non-neoplastic human thyroid cells. Cancer 1992 69 1799 1807.
36. Lindhorst E, Schumm-Draeger PM, Bojunga J, Usadel KH, Herrmann G. Differences in tumor cell proliferation, HLA DR expression and lymphocytic infiltration in various types of thyroid carcinoma. Exp. Clin. Endocrinol. Diabetes 2002 110 27 31.
37. Arif S, Patel J, Blanes A, Diaz-Cano SJ. Gene expression and phenotype in follicular thyroid neoplasms. Lab. Invest. 2004 84 321A.